🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
666 results for “pharmaceuticals”
MedicineActive substanceLicence holderStatus
Olazax Disperzi 15 mg orodispersible tablets
EU/1/09/592/004
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 20 mg orodispersible tablets
EU/1/09/592/005
Olanzapine Glenmark Pharmaceuticals s.r.o.
Olazax Disperzi 5 mg orodispersible tablets
EU/1/09/592/001
Olanzapine Glenmark Pharmaceuticals s.r.o.
Omeprazole Bluefish 10 mg gastro-resistant capsules
PA1436/007/001
Omeprazole Bluefish Pharmaceuticals AB Marketed
Omeprazole Bluefish 20 mg gastro-resistant capsules
PA1436/007/002
Omeprazole Bluefish Pharmaceuticals AB Marketed
Omeprazole Bluefish 40 mg gastro-resistant capsules
PA1436/007/003
Omeprazole Bluefish Pharmaceuticals AB Marketed
Omeprazole Rowa 20 mg Gastro-resistant Capsules, hard
PA0074/075/002
Omeprazole Rowa Pharmaceuticals Limited, Marketed
Omeprazole Rowa 40 mg Gastro-Resistant Capsules, hard
PA0074/075/003
Omeprazole Rowa Pharmaceuticals Limited, Marketed
Opsaren 10 mg Film-coated Tablets
PA22865/018/001
Macitentan Renata Pharmaceuticals (Ireland) Limited Not marketed
Oramox 125 mg/5 ml powder for oral suspension
PA1418/013/001
Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 250 mg hard capsules
PA1418/013/003
Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 250 mg/5 ml powder for oral suspension
PA1418/013/002
Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 500 mg hard capsules
PA1418/013/004
Amoxicillin Athlone Pharmaceuticals Limited Marketed
Orkambi 100 mg/125 mg film-coated tablets
EU/1/15/1059/005
Lumacaftor, Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Orkambi 100 mg/125 mg granules in sachet
EU/1/15/1059/006
Lumacaftor, Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Orkambi 150 mg/188 mg granules in sachet
EU/1/15/1059/007
Ivacaftor, Lumacaftor Vertex Pharmaceuticals (Ireland) Limited
Orkambi 200 mg/125 mg film-coated tablets
EU/1/15/1059/001
Lumacaftor, Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
Orkambi 75 mg/94 mg granules in sachet
EU/1/15/1059/008
Lumacaftor, Ivacaftor Vertex Pharmaceuticals (Ireland) Limited
OxyContin 10 mg prolonged release tablets
PA1688/005/002
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyContin 20 mg prolonged release tablets
PA1688/005/003
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyContin 40 mg prolonged release tablets
PA1688/005/004
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyContin 5 mg prolonged release tablets
PA1688/005/001
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyContin 80 mg prolonged release tablets
PA1688/005/005
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Not marketed
OxyNorm 10 mg hard capsules
PA1688/006/005
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm 10 mg/ml, solution for injection or infusion
PA1688/006/001
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm 20 mg hard capsules
PA1688/006/006
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm 5 mg hard capsules
PA1688/006/004
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm 50 mg/ml, solution for injection or infusion
PA1688/006/010
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm concentrate 10 mg/ml oral solution
PA1688/006/003
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm Dispersa 10 mg Orodispersible Tablets
PA1688/006/008
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm Dispersa 20 mg orodispersible tablets
PA1688/006/009
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm Dispersa 5 mg Orodispersible Tablets
PA1688/006/007
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
OxyNorm liquid 1 mg/ml oral solution
PA1688/006/002
OXYCODONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
Palladone 1.3 mg hard capsules
PA1688/007/001
Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Palladone 2.6 mg hard capsules
PA1688/007/002
Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Not marketed
Palladone SR 2 mg prolonged release hard capsules
PA1688/007/007
Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Palladone SR 4 mg prolonged release hard capsules
PA1688/007/008
Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Palladone SR 8 mg prolonged release hard capsules,
PA1688/007/009
Hydromorphone hydrochloride Mundipharma Pharmaceuticals Limited Marketed
Pantoprazole Bluefish 20 mg gastro-resistant tablets
PA1436/008/001
Pantoprazole sodium sesquihydrate Bluefish Pharmaceuticals AB Marketed
Pantoprazole Bluefish 40 mg gastro-resistant tablets
PA1436/008/002
Pantoprazole sodium sesquihydrate Bluefish Pharmaceuticals AB Marketed
Pantup 20 mg gastro-resistant tablets
PA0074/069/001
Pantoprazole Rowa Pharmaceuticals Limited, Not marketed
Pantup 40 mg gastro-resistant tablets
PA0074/069/002
Pantoprazole Rowa Pharmaceuticals Limited, Not marketed
Paracetamol 500 mg Capsules, hard
PA22871/016/001
Paracetamol Azure Pharmaceuticals Ltd. Not marketed
Paracetamol 500 mg tablets
PA1436/040/001
Paracetamol Bluefish Pharmaceuticals AB Not marketed
Paracetamol/Ibuprofen 1000 mg/300mg powder for oral solution in sachet
PA25595/001/002
Paracetamol, Ibuprofen lysine Aft Pharmaceuticals (Eur) Limited Not marketed
Paracetamol/Ibuprofen 500 mg/150 mg powder for oral solution in sachet
PA25595/001/001
Paracetamol, Ibuprofen lysine Aft Pharmaceuticals (Eur) Limited Not marketed
Paracetamol/Ibuprofen Vale 1000 mg/300mg powder for oral solution in sachet
PA1535/018/002
Paracetamol, Ibuprofen lysine Vale Pharmaceuticals Limited Not marketed
Paracetamol/Ibuprofen Vale 500 mg/150 mg powder for oral solution in sachet
PA1535/018/001
Paracetamol, Ibuprofen lysine Vale Pharmaceuticals Limited Not marketed
Paxneury 1 mg prolonged-release tablets
EU/1/24/1908/001
Guanfacine hydrochloride Neuraxpharm Pharmaceuticals S.L.
Paxneury 2 mg prolonged-release tablets
EU/1/24/1908/002
Guanfacine hydrochloride Neuraxpharm Pharmaceuticals S.L.
6 7 8 9 10 11 12
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 1 September 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.